Document and Entity Information
Document and Entity Information - USD ($) | 12 Months Ended | ||
Aug. 31, 2022 | Nov. 28, 2022 | Feb. 28, 2022 | |
Cover [Abstract] | |||
Entity Registrant Name | ENERTOPIA CORP. | ||
Entity Central Index Key | 0001346022 | ||
Document Period End Date | Aug. 31, 2022 | ||
Current Fiscal Year End Date | --08-31 | ||
Document Type | 10-K | ||
Amendment Flag | false | ||
Document Annual Report | true | ||
Document Transition Report | false | ||
Entity File Number | 000-51866 | ||
Document Fiscal Period Focus | FY | ||
Document Fiscal Year Focus | 2022 | ||
Entity Incorporation, State or Country Code | NV | ||
Entity Tax Identification Number | 20-1970188 | ||
Entity Address, Address Line One | #18 1873 SPALL RD. | ||
Entity Address, City or Town | KELOWNA | ||
Entity Address, State or Province | BC | ||
Entity Address, Country | CA | ||
Entity Address, Postal Zip Code | V1Y 4R2 | ||
City Area Code | 250 | ||
Local Phone Number | 870-2219 | ||
Entity Public Float | $ 6,271,346 | ||
Entity Well Known Seasoned Issuer | No | ||
Entity Voluntary Filers | No | ||
Entity Current Reporting Status | Yes | ||
Entity Common Stock, Shares Outstanding | 155,116,088 | ||
Entity Filer Category | Non-accelerated Filer | ||
Entity Small Business | true | ||
Entity Interactive Data Current | Yes | ||
Entity Emerging Growth Company | false | ||
Entity Shell Company | false | ||
Auditor Name | DAVIDSON & COMPANY LLP | ||
Auditor Location | Vancouver, Canada | ||
Auditor Firm ID | 731 |
BALANCE SHEETS
BALANCE SHEETS - USD ($) | Aug. 31, 2022 | Aug. 31, 2021 |
Current | ||
Cash | $ 615,207 | $ 354,286 |
Marketable securities | 2,443,750 | 14,994 |
Accounts receivable | 4,877 | 4,552 |
Prepaid expenses and deposit | 139,307 | 41,263 |
Total current assets | 3,203,141 | 415,095 |
Non-Current | ||
Mineral property | 10,500 | 0 |
Total Assets | 3,213,641 | 415,095 |
Current | ||
Accounts payable | 293,446 | 309,277 |
Due to related parties | 64,409 | 111,659 |
Total Liabilities | 357,855 | 420,936 |
STOCKHOLDERS' EQUITY (DEFICIENCY) | ||
Share capital Authorized: 200,000,000 common shares with a par value of $0.001 per share Issued and outstanding: 155,116,088 common shares at August 31, 2022 and August 31,2021: 139,211,700 | 155,117 | 139,213 |
Additional paid-in capital | 15,395,657 | 14,524,341 |
Deficit | (12,694,988) | (14,669,395) |
Total Stockholders' Equity (Deficiency) | 2,855,786 | (5,841) |
Total Liabilities and Stockholders' Equity (Deficiency) | $ 3,213,641 | $ 415,095 |
BALANCE SHEETS (Parentheticals)
BALANCE SHEETS (Parentheticals) - $ / shares | Aug. 31, 2022 | Aug. 31, 2021 |
Statement of Financial Position [Abstract] | ||
Common stock, shares authorized | 200,000,000 | 200,000,000 |
Common stock, par value per share | $ 0.001 | $ 0.001 |
Common stock, shares issued | 155,116,088 | 139,211,700 |
Common stock, shares outstanding | 155,116,088 | 139,211,700 |
STATEMENTS OF STOCKHOLDERS' EQU
STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIENCY) - USD ($) | Common Stock [Member] | ADDITIONAL PAID-IN CAPITAL [Member] | DEFICIT [Member] | Total |
Beginning Balance (shares) at Aug. 31, 2020 | 128,471,700 | |||
Beginning Balance at Aug. 31, 2020 | $ 128,473 | $ 13,758,598 | $ (14,280,027) | $ (392,956) |
Shares issued for patent (shares) | 2,000,000 | |||
Shares issued for patent | $ 2,000 | 67,000 | 69,000 | |
Private placement (shares) | 3,000,000 | |||
Private placement | $ 3,000 | 177,000 | $ 180,000 | |
Warrants exercised (shares) | 2,720,000 | 2,720,000 | ||
Warrants exercised | $ 2,720 | 131,080 | $ 133,800 | |
Stock options granted | 297,691 | $ 297,691 | ||
Stock options exercised (shares) | 3,020,000 | 3,293,224 | ||
Stock options exercised | $ 3,020 | 92,972 | $ 95,992 | |
Comprehensive income / loss | (389,368) | (389,368) | ||
Ending Balance (shares) at Aug. 31, 2021 | 139,211,700 | |||
Ending Balance at Aug. 31, 2021 | $ 139,213 | 14,524,341 | (14,669,395) | $ (5,841) |
Warrants exercised (shares) | 2,791,000 | 2,791,000 | ||
Warrants exercised | $ 2,791 | 128,599 | $ 131,390 | |
Stock options granted | 163,130 | 163,130 | ||
Shares issued for hydrogen technology (shares) | 2,000,000 | |||
Shares issued for hydrogen technology | $ 2,000 | 98,400 | 100,400 | |
Shares issued for investment in battery management technology (shares) | 10,000,000 | |||
Shares issued for investment in battery management technology | $ 10,000 | 440,000 | 450,000 | |
Shares issued for services (shares) | 1,000,000 | |||
Shares issued for services | $ 1,000 | 41,300 | $ 42,300 | |
Stock options exercised (shares) | 113,388 | 113,388 | ||
Stock options exercised | $ 113 | (113) | $ 0 | |
Comprehensive income / loss | 1,974,407 | 1,974,407 | ||
Ending Balance (shares) at Aug. 31, 2022 | 155,116,088 | |||
Ending Balance at Aug. 31, 2022 | $ 155,117 | $ 15,395,657 | $ (12,694,988) | $ 2,855,786 |
STATEMENTS OF OPERATIONS AND CO
STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS) - USD ($) | 12 Months Ended | |
Aug. 31, 2022 | Aug. 31, 2021 | |
Expenses | ||
Accounting and audit | $ 43,770 | $ 44,655 |
Bank charges and interest expense | 6,251 | 1,416 |
Consulting | 262,880 | 367,579 |
Mineral exploration costs | 212,348 | 7,888 |
Fees and dues | 57,332 | 35,828 |
Investor relations | 47,917 | 49,718 |
Legal and professional | 67,257 | 83,307 |
Office and miscellaneous | 22,525 | 4,708 |
Research and development | 808,800 | 12,566 |
Rent | 10,404 | 7,042 |
Telephone | 19 | 75 |
Travel | 26,732 | 0 |
Total expenses | 1,566,235 | 614,782 |
Loss for the year before other items | (1,566,235) | (614,782) |
Other income (expense) | ||
Foreign exchange gain (loss) | 1,822 | (3,394) |
Gain (loss) on marketable securities | (7,641) | 53,488 |
Unrealized loss on marketable securities | (923,533) | (5,680) |
Unrealized foreign exchange loss on marketable securities | 62,388 | 0 |
Write down of assets | 0 | (69,000) |
Income from royalty granted | 0 | 250,000 |
Gain from mineral property sale | 4,532,382 | 0 |
Income (loss) and comprehensive income (loss) for the year | $ 1,974,407 | $ (389,368) |
Income (loss) per share | ||
Basic | $ 0.01 | $ 0 |
Diluted | $ 0.01 | $ 0 |
Weighted average number of common shares outstanding | ||
Basic | 150,994,325 | 134,809,673 |
Diluted | 151,955,536 | 134,809,673 |
STATEMENTS OF CASH FLOWS
STATEMENTS OF CASH FLOWS - USD ($) | 12 Months Ended | |
Aug. 31, 2022 | Aug. 31, 2021 | |
Cash flows used in operating activities | ||
Net Income/(Loss) | $ 1,974,407 | $ (389,368) |
Changes to reconcile net loss to net cash used in operating activities | ||
Shares issued for consulting | 42,300 | 0 |
Shares issued for battery management system | 450,000 | 0 |
Shares issued for hydrogen technology | 100,400 | 0 |
Stock-based compensation | 163,130 | 297,691 |
Unrealized loss on marketable securities | 985,921 | 5,680 |
Loss (gain) on disposal of marketable securities | 7,641 | (53,488) |
Write down of assets | 0 | 69,000 |
Gain on mineral property sale | (4,532,382) | 0 |
Income from royalty grant | 0 | (250,000) |
Change in non-cash working capital items: | ||
Accounts receivable | (325) | (3,044) |
Prepaid expenses and deposit | (98,044) | (26,439) |
Accounts payable and accrued liabilities | (15,831) | 18,941 |
Due to related parties | (47,250) | (77,175) |
Net cash used in operating activities | (970,033) | (408,202) |
Cash flows from investing activities | ||
Proceeds from sale of marketable securities | 10,064 | 74,873 |
Proceeds from mineral property sale | 1,100,000 | 0 |
Purchase of mineral property | (10,500) | 0 |
Purchase of marketable securities | 0 | (17,705) |
Proceeds from sale of royalty grant | 0 | 250,000 |
Net cash from investing activities | 1,099,564 | 307,168 |
Cash flows from financing activities | ||
Net proceeds from options exercised | 0 | 95,992 |
Net proceeds from warrants exercised | 131,390 | 133,800 |
Net proceeds from subscriptions received | 0 | 180,000 |
Net cash from financing activities | 131,390 | 409,792 |
Increase in cash | 260,921 | 308,758 |
Cash, beginning of year | 354,286 | 45,528 |
Cash, end of year | 615,207 | 354,286 |
Supplemental cash flow information | ||
Cash paid for interest | 0 | 0 |
Cash paid for taxes | $ 0 | $ 0 |
ORGANIZATION
ORGANIZATION | 12 Months Ended |
Aug. 31, 2022 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
ORGANIZATION [Text Block] | 1. ORGANIZATION The Company was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. The Company is an independent natural resource company engaged in the exploration, development, and acquisition of natural resources in the United States. The Company is exploring the West Tonopah Lithium Project ("West Tonopah") in the Big Smokey Valley, Nevada The Company is also developing various renewable energy technologies. The Company's office is located in Kelowna, B.C., Canada. |
GOING CONCERN UNCERTAINTY
GOING CONCERN UNCERTAINTY | 12 Months Ended |
Aug. 31, 2022 | |
Going Concern Uncertainty [Abstract] | |
GOING CONCERN UNCERTAINTY [Text Block] | 2. GOING CONCERN UNCERTAINTY The accompanying financial statements have been prepared on a going concern basis which contemplates the realization of assets and the satisfaction of liabilities and commitments in the normal course of business for the foreseeable future. The Company had a working capital of $2,845,286 as at August 31, 2022 (2021 - $5,841 deficit). As at August 31, 2022 the Company has incurred cumulative losses of $12,694,988 that raises substantial doubt about its ability to continue as a going concern. Management has been able, thus far, to finance the operations through equity financing and cash on hand. There is no assurance that the Company will be able to continue to finance the Company on this basis. In view of these conditions, the ability of the Company to continue as a going concern is in substantial doubt and dependent upon its ability to generate sufficient cash flow to meet its obligations on a timely basis, to obtain additional financing as may be required, to receive the continued support of the Company's shareholders, and ultimately to obtain successful operations. There are no assurances that we will be able to obtain further funds required for our continued operations. As noted herein, we are pursuing various financing alternatives to meet our immediate and long-term financial requirements. There can be no assurance that additional financing will be available to us when needed or, if available, that it can be obtained on commercially reasonable terms. If we are not able to obtain the additional financing on a timely basis, we will be unable to conduct our operations as planned, and we will not be able to meet our other obligations as they become due. In such event, we will be forced to scale down or perhaps even cease our operations. There is significant uncertainty as to whether we can obtain additional financing. These financial statements do not give effect to any adjustments which would be necessary should the Company be unable to continue as a going concern and therefore be required to realize its assets and discharge its liabilities in other than the normal course of business and at amounts different from those reflected in the accompanying financial statements. Since March 2020, several measures have been implemented in Canada, the United States, and the rest of the world in response to the impact from the novel coronavirus ("COVID-19"). While the impact of COVID-19 is expected to be temporary, the current circumstances are dynamic and the impact on our business operations cannot be reasonably estimated at this time. We anticipate this could have an adverse impact on our exploration plans, results of operations, financial position and cash flows. |
SIGNIFICANT ACCOUNTING POLICIES
SIGNIFICANT ACCOUNTING POLICIES | 12 Months Ended |
Aug. 31, 2022 | |
Accounting Policies [Abstract] | |
SIGNIFICANT ACCOUNTING POLICIES [Text Block] | 3. SIGNIFICANT ACCOUNTING POLICIES a. Basis of Presentation The accompanying financial statements have been prepared in accordance with U.S. generally accepted accounting principles. b. Mineral Properties Acquisition costs of mineral rights are initially capitalized as incurred while exploration and pre-extraction expenditures are expensed as incurred until such time proven or probable reserves are established for that project. Acquisition costs include cash consideration and the fair market value of shares issued on the acquisition of mineral properties. Expenditures relating to exploration activities are expensed as incurred and expenditures relating to pre-extraction activities are expensed as incurred until such time proven or probable reserves are established for that project, after which subsequent expenditures relating to development activities for that particular project are capitalized as incurred. Where proven and probable reserves have been established, the project's capitalized expenditures are depleted over proven and probable reserves using the units-of production method upon commencement of production. Where proven and probable reserves have not been established, the project's capitalized expenditures are depleted over the estimated extraction life using the straight-line method upon commencement of extraction. The Company has not established proven or probable reserves for any of its projects. The carrying values of the mineral rights are assessed for impairment by management on a quarterly basis and as required whenever indicators of impairment exist. An impairment loss is recognized if it is determined that the carrying value is not recoverable and exceeds fair value. c. Stock-Based Compensation The Company followed Accounting Standards Codification ("ASC") 718, "Compensation - Stock Compensation", to account for its stock options and similar equity instruments issued. Accordingly, compensation costs attributable to stock options or similar equity instruments granted are measured at the fair value at the grant date, and expensed over the expected vesting period. ASC 718 requires excess tax benefits be reported as a financing cash inflow rather than as a reduction of taxes paid. d. Accounting Estimates The preparation of financial statements in conformity with U.S GAAP requires us to make certain estimates, judgements and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Some of the Company's accounting policies require us to make subjective judgments, often as a result of the need to make estimates of matters that are inherently uncertain. These accounting policies involve critical accounting estimates because they are particularly dependent on estimates and assumptions made by management about matters that are highly uncertain at the time the accounting estimates are made. Although we have used our best estimates based on facts and circumstances available to us at the time, different estimates reasonably could have been used. Changes in the accounting estimates used by the Company are reasonably likely to occur from time to time, which may have a material effect on the presentation of financial condition and results of operations. The Company reviews these estimates, judgments and assumptions periodically and reflect the effects of revisions in the period in which they are deemed to be necessary. We believe that these estimates are reasonable; however, actual results could differ from these estimates. Significant accounting estimates and assumptions are used for, but not limited to: a) Judgement is required in determining whether deferred tax assets are recognized on the balance sheet. The recognition of deferred tax assets requires management to assess the likelihood that the Company will generate taxable income in future periods to utilize the deferred tax assets. Due to the Company's history of losses, deferred tax assets have not been recognized by the Company. b) The Company provides compensation benefits to its employees, directors, officers, and consultants, through a stock option plan. The fair value of each option award is estimated on the date of grant using the Black-Scholes option pricing model. Expected volatility assumption used in the model is based on the historical volatility of the Company's share price. The Company uses historical data to estimate the period of option exercises for use in the valuation model. The risk-free interest rate for the expected term of the option is based on the yields of government bonds. Changes in these assumptions, especially the share price volatility and the expected life determination could have a material impact on the Company's profit and loss for the periods presented. All estimates used in the model are based on historical data which may not be representative of future results. c) The Company at times grants common shares in lieu of cash to certain vendors for their services to the Company. The Company recognizes the associated cost in the same period and manner as if the Company paid cash for the services provided by calculating the fair value of the share offering at the cost of the service provided. e. Earnings Per Share Loss per share is computed using the weighted average number of shares outstanding during the period. f. Foreign Currency Translations The Company's operations are located in the United States of America and has its office in Canada. The Company maintains its accounting records in U.S. Dollars, as follows: At the transaction date, each asset, liability, revenue and expense that was acquired or incurred in a foreign currency is translated into U.S. dollars by the using of the exchange rate in effect at that date. At the year end, monetary assets and liabilities are translated at the exchange rate in effect at that date. The resulting foreign exchange gains and losses are included in operations. g. Financial Instruments ASC 820 "Fair Value Measurements and Disclosures" requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. ASC 820 establishes a fair value hierarchy based on the level of independent, objective evidence surrounding the inputs used to measure fair value. A financial instrument's categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. ASC 820 prioritizes the inputs into three levels that may be used to measure fair value: Level 1 - Quoted prices in active markets for identical assets or liabilities; Level 2 - Inputs other than quoted prices included within Level 1 that are either directly or indirectly observable; and Level 3 - Unobservable inputs that are supported by little or no market activity, therefore requiring an entity to develop its own assumptions about the assumptions that market participants would use in pricing. The Company's financial instruments consist primarily of cash, marketable securities, The Company's operations are in United States of America and Canada, which results in exposure to market risks from changes in foreign currency rates. The financial risk is the risk to the Company's operations that arise from fluctuations in foreign exchange rates and the degree of volatility of these rates. Currently, the Company does not use derivative instruments to reduce its exposure to foreign currency risk. h. Income Taxes The Company has adopted ASC 740, "Income Taxes", which requires the Company to recognize deferred tax liabilities and assets for the expected future tax consequences of events that have been recognized in the Company's financial statements or tax returns using the liability method. Under this method, deferred tax liabilities and assets are determined based on the temporary differences between the financial statement and tax bases of assets and liabilities using enacted tax rates in effect in the year in which the differences are expected to reverse. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the period that includes the enactment date. In addition, a valuation allowance is established to reduce any deferred tax asset for which it is determined that it is more likely than not that some portion of the deferred tax asset will not be realized. i. Long-Lived Assets Impairment In accordance with ASC 360, "Accounting for Impairment or Disposal of Long Lived Assets", the carrying value of long lived assets are tested for recoverability whenever events or changes in circumstances indicate that its carrying amount may not be recoverable. The Company recognizes impairment when the sum of the expected undiscounted future cash flows is less than the carrying amount of the asset. Impairment losses, if any, are measured as the excess of the carrying amount of the asset over its estimated fair value. j. Asset Retirement Obligations The Company accounts for asset retirement obligations in accordance with the provisions of ASC 410, "Asset Retirement and Environmental Obligations". ASC 410 requires the Company to record the fair value of an asset retirement obligation as a liability in the period in which it incurs a legal obligation associated with the retirement of tangible long-lived assets that result from the acquisition, construction, development and/or normal use of the assets. The Company does not believe it has any asset retirement obligation as of August 31, 2022 and 2021. k. Comprehensive Income The Company has adopted ASC 220, "Comprehensive Income", which establishes standards for reporting and display of comprehensive income, its components and accumulated balances. The Company is disclosing this information on its Statement of Stockholders' Deficiency. Comprehensive income comprises equity except those transactions resulting from investments by owners and distributions to owners. l. Concentration of credit risk The Company places its cash with high credit quality financial institutions. m. Commitments and Contingencies In accordance with ASC 450-20, "Accounting for Contingencies", the Company records accruals for such loss contingencies when it is probable that a liability has been incurred and the amount of loss can be reasonably estimated. In the event that estimates or assumptions prove to differ from actual results, adjustments are made in subsequent periods to reflect more current information. Historically, the Company has not experienced any material claims. n. Research and Development Research and development costs are expensed as incurred. |
MARKETABLE SECURITIES
MARKETABLE SECURITIES | 12 Months Ended |
Aug. 31, 2022 | |
Investments, Debt and Equity Securities [Abstract] | |
MARKETABLE SECURITIES [Text Block] | 4. MARKETABLE SECURITIES On May 4, 2022 ("Closing Date"), the Company announced the sale of its Clayton Valley unpatented mining claims to Cypress Development Corporation ("Cypress") and as a result of this transaction received 3,000,000 shares of Cypress along with $1,100,000 in cash. The 3,000,000 shares have been restricted for trade: the Company may trade 1,000,000 of these shares six months and one day after the Closing Date and thereafter may trade 1,000,000 shares in each three-month period following the Closing Date. Given the lock up conditions, the Company believes that there is a Lack of Marketability ("LOM") related to these shares and thus recorded the shares using a discounting factor. The discounting factor was also used in fair valuing the shares as at the year end date of August 31, 2022. Marketable securities as at August 31, 2022 consist of the Company's investment in 3,000,000 shares of Cypress. As at August 31, 2022, the movement in the Company's marketable securities is as follows: Balance, August 31, 2020 $ 24,354 Additions 17,705 Proceeds from disposals (21,385 ) Unrealized loss (5,680 ) Balance, August 31, 2021 $ 14,994 Additions 1 3,432,382 Unrealized loss (923,533 ) Unrealized foreign exchange loss ( 62,388 ) Proceeds from disposal ( 10,064 ) Loss on disposal (7,641 ) Balance, August 31, 2022 $ 2,443,750 1 |
MINERAL PROPERTY
MINERAL PROPERTY | 12 Months Ended |
Aug. 31, 2022 | |
Mineral Industries Disclosures [Abstract] | |
MINERAL PROPERTY [Text Block] | 5. MINERAL PROPERTY Clayton Valley During the year ended August 31, 2017 the Company staked lode and placer claims on Bureau of Land Management lands in Esmerelda county Nevada covering approximately 160 Acres subject to adjustment. The Company has a 100% interest in the lands and is only responsible for the yearly maintenance fees to keep its 100% interest. On February 11, 2020 the Company signed a 1% Royalty agreement with respect to any future commercial lithium production from the Company's Clayton Valley, Nevada claims in exchange for $200,000. The Company has a right of first refusal to repurchase the royalty upon any proposed sale by the royalty holder to a third party. On October 30, 2020 the Company signed a 1% Royalty agreement with respect to any future commercial lithium production from the Company's Clayton Valley, Nevada claims in exchange for $250,000. The Company has a right of first refusal to repurchase the royalty upon any proposed sale by the royalty holder to a third party. On May 4, 2022, the Company closed the Clayton Valley property sale and disposed of the unpatented mining claims for consideration consisting of $1,100,000 in cash and 3,000,000 shares of Cypress Development Corp (Note 4). The royalty liabilities from the project were transferred to Cypress Development Corp. West Tonopah On February 25, 2022, the Company staked 1,760 acres of unpatented mineral claims in Esmeralda County, Nevada for cash consideration of $10,500. |
TECHNOLOGY DEVELOPMENT
TECHNOLOGY DEVELOPMENT | 12 Months Ended |
Aug. 31, 2022 | |
Technology Development [Abstract] | |
TECHNOLOGY DEVELOPMENT [Text Block] | 6. TECHNOLOGY DEVELOPMENT On December 14, 2020 the Company signed Definitive Agreement to acquire 100% interest in United States Patent and Trademark Office ("USPTO") patent #6,024,086 - Solar energy collector having oval absorption tubes by issuing 1,000,000 common shares of the Company. The Company issued 1,000,000 additional common shares in escrow to be released upon the successful approval of patent pending work derived from patent #6,024,086. The shares were issued at a price of $0.0345 resulting in a purchase price of $69,000. The patent has since expired and was therefore written off. On May 25, 2021 the Company announced the filing of its first provisional patent application, Solar Heat Absorber technology. On May 26, 2021 the Company announced the filing of its second provisional patent application, Solar PV Heat Extraction Technology. On August 17, 2021 the Company announced the filing of provisional patent #3, known as Enertopia Rainmaker TM On December 6, 2021, The Company entered into a Definitive Purchase and Sale Agreement to acquire 100% ownership and rights to the hydrogen technology (“Hydrogen Technology”). By acquiring this Hydrogen Technology, the Company is currently researching the opportunity to create process gas that can be used in commercial, industrial and mining applications by splitting the hydrogen from water via electrolysis. The Company paid $25,000 in cash and issued 1,000,000 shares in consideration for acquiring the Hydrogen Technology, with an additional 1,000,000 common shares issued and held in escrow pending successful patenting of the intellectual property. The Company has recorded the consideration for the purchase of the Hydrogen Technology as research and development expense in the statement of operations for the year ended August 31, 2022, as follows: Consideration for Purchase of Hydrogen Technology Amount $ 2,000,000 shares at FV 0.0502 (Adjusted closing price on the date of the issuance) 100,400 Cash Payment 25,000 Total 125,400 The technology is still in research and development phase and is not commercially feasible as at the year end date of August 31, 2022. The Company has incurred $168,016 as research and development costs for the hydrogen technology, in addition to the $125,400 acquisition related costs for the year ended August 31, 2022. |
BATTERY MANAGEMENT TECHNOLOGY (
BATTERY MANAGEMENT TECHNOLOGY ("BMT") | 12 Months Ended |
Aug. 31, 2022 | |
Battery Management Technology [Abstract] | |
BATTERY MANAGEMENT TECHNOLOGY ("BMT") [Text Block] | 7. BATTERY MANAGEMENT TECHNOLOGY ("BMT") On December 17, 2021, The Company entered into a Definitive Purchase and Sale Agreement to acquire 100% ownership and rights to their Provisional Patent Pending BMT. The Company created a Joint Venture ("JV") with 51% controlling interest in CapNTrack to run the commercial and industrial operations related to the BMT and has paid $30,000 in cash and issued 10,000,000 shares (5,000,000 shares of which are in escrow) valued at $450,000 for purchase of the BMT. As at the year ended date of August 31, 2022, there have been no operations in the JV and it is a dormant entity. The BMT is still in research and development phase and has not obtained commercial or operational feasibility as at the year end date of August 31, 2022. The Company has recorded the entire consideration of $480,000 for the ownership of the BMT as research and development expense in the statement of operations for the year ended August 31, 2022. |
RELATED PARTY TRANSACTIONS
RELATED PARTY TRANSACTIONS | 12 Months Ended |
Aug. 31, 2022 | |
Related Party Transactions [Abstract] | |
RELATED PARTY TRANSACTIONS [Text Block] | 8. RELATED PARTY TRANSACTIONS For the year ended August 31, 2022, the Company was party to the following related party transactions with key management personnel, which consists of the President and Chief Financial Officer of the Company and its Directors: Incurred $38,000 (2021 - $0) to the President of the Company in consulting fees. As at August 31, 2022, the accounts payable to the President of the Company was $64,409 (2021: $111,659). On December 6, 2021 the Company issued 250,000 stock options valued at $12,205 to the President of the Company (Note 10). Incurred $769 (2021 - $0) to the Chief Financial Officer of the Company in consulting fees. As at August 31, 2022, the accounts payable to the Chief Financial Officer of the Company was $0 (2021: $0). ). On August 18, 2022, the Company issued 1,000,000 stock options valued at $40,543 to the Chief Financial Officer of the Company (Note 10). On August 18, 2022 the Company issued a total of 1,000,000 stock options valued at $40,543 to the Directors of the Company. On December 6, 2021, the Company issued a total of 250,000 stock options valued at $12,205 to the president of the Company. The related party transactions are recorded at the exchange amount established and agreed to between the related parties. |
COMMON STOCK
COMMON STOCK | 12 Months Ended |
Aug. 31, 2022 | |
Stockholders' Equity Note [Abstract] | |
COMMON STOCK [Text Block] | 9. COMMON STOCK On December 14, 2020 the Company issued 1,000,000 common shares and an additional 1,000,000 common shares in escrow in connection with the signed Definitive Agreement (Note 6). On January 14, 2021 the Company closed the final tranche of a private placement of 3,000,000 units at a price of $0.06 per unit for gross proceeds of $180,000. Each unit consists of one common share of the Company and one half (0.5) of a non-transferable share purchase warrant, each warrant entitling the holder to purchase one additional common share of the Company for a period of 12 months from the date of issuance at a purchase price of $0.09. During the year ended August 31, 2021 the Company also issued 3,020,000 common shares as a result of the exercise of stock options and 2,720,000 common shares as a result of the exercise of warrants (Note 10). During the year ended August 31, 2022 the Company issued 113,388 common shares as a result of the exercise of stock options and 2,791,000 common shares as a result of the exercise of warrants (Note 10). On December 6, 2021 the Company issued 1,000,000 common shares and an additional 1,000,000 common shares in escrow in connection with the purchase of Hydrogen Technology (Note 6). On December 17, 2021 the Company issued 5,000,000 common shares and an additional 5,000,000 common shares in escrow in connection with the purchase of JV (Note 7). On February 25, 2022, the Company issued 1,000,000 shares to one consultant of the Company. As at August 31, 2022 the Company had 155,116,088 shares issued and outstanding (2021 - 139,211,700). As at August 31, 2022 the Company had 7,000,000 (2021 - 1,000,000) shares held in escrow. |
STOCK OPTIONS AND WARRANTS
STOCK OPTIONS AND WARRANTS | 12 Months Ended |
Aug. 31, 2022 | |
Share-based Payment Arrangement [Abstract] | |
STOCK OPTIONS AND WARRANTS [Text Block] | 10. STOCK OPTIONS AND WARRANTS Stock Options On July 15, 2014, the shareholders approved and adopted at the Annual General Meeting the Company's 2014 Stock Option Plan. The purpose of these Plans is to advance the interests of the Corporation, through the grant of Options, by providing an incentive mechanism to foster the interest of eligible persons in the success of the Corporation and its affiliates; encouraging eligible persons to remain with the Corporation or its affiliates; and attracting new Directors, Officers, Employees and Consultants. On November 12, 2020, the Company issued 500,000 stock options to one of the consultants of the Company with an exercise price of $0.05 vested immediately, expiring November 12, 2025. On December 14, 2020, the Company issued 2,100,000 stock options to consultants and officers of the Company with an exercise price of $0.05 vested immediately, expiring December 14, 2025. On January 28, 2021, the Company issued 2,000,000 stock options to one of the consultants of the Company with an exercise price of $0.14 vested immediately, expiring January 28, 2026. On February 4, 2021, the Company issued 100,000 stock options to one of the consultants of the Company with an exercise price of $0.18 vested immediately, expiring February 4, 2026. On February 5, 2021, the Company issued 300,000 stock options to three of the consultants of the Company with an exercise price of $0.18 vested immediately, expiring February 5, 2026. On April 27, 2021, the Company issued 100,000 stock options to one of the consultants of the Company with an exercise price of $0.12 vested immediately, expiring April 27, 2026. On May 28, 2021, the Company issued 50,000 stock options to one of the consultants of the Company with an exercise price of $0.12 vested immediately, expiring May 28, 2026. On August 18, 2022, the Company issued 2,000,000 stock options with an exercise price of $ 0.06 vesting immediately, expiring August 18, 2027. 1,000,000 to the Chief Financial Officer and 500,000 each to two Directors of the Company (Note 8). O n December 6, 2021, the Company issued 250,000 stock options to the president of the Company with an exercise price of $0.07 vested immediately, expiring December 6, 2026. On December 6, 2021, the Company issued 500,000 stock options to one of the consultants of the Company with an exercise price of $ 0.07 vested immediately, expiring December 6, 2026. On December 6, 2021, the Company issued 250,000 stock options to one of the consultants of the Company with an exercise price of $ 0.07 vested immediately, expiring December 6, 2026. On September 9, 2021, the Company issued 500,000 stock options to one of the consultants of the Company with an exercise price of $ 0.08 vested immediately, expiring September 9, 2026. The fair value of the options granted during the year ended August 31, 2022 and 2021 was estimated on the date of the grant using the Black-Scholes options pricing model, with the following weighted average assumptions: 2022 2021 Expected dividend yield 0.00% 0.00% Expected stock volatility 202% 98% Risk-free interest rate 2.26% 0.41% Expected life of options (years) 5.00 5.00 Expected forfeiture rate 0.00% 0.00% Grant date fair value per option $ 0.05 $ 0.06 During the year ended August 31, 2022, the Company recorded $163,130 (August 31, 2021 $297,691) as stock-based compensation expense. In addition, the Company issued 113,388 (August 31, 2021: 3,293,224) common shares of the Company as a result of exercise of 226,776 cashless stock options and a total of 3,450,000 stock options expired without being exercised (August 31, 2021: 1,100,000). A summary of the changes in stock options is presented below: Options Outstanding Weighted Average Number of Shares Exercise Price Balance, August 31, 2020 9,320,000 $ 0.06 Issued 5,150,000 0.10 Expired (1,100,000 ) 0.05 Exercised (3,293,224 ) 0.04 Balance, August 31, 2021 10,076,776 $ 0.08 Issued 3,500,000 0.07 Expired (3,450,000 ) 0.07 Exercised (226,776 ) 0.04 Balance, August 31, 2022 9,900,000 $ 0.08 The Company has the following options outstanding and exercisable as at August 31, 2022: Issue Date Expiry Date Exercise Price Number of Options Remaining Life October 27, 2017 October 27, 2022 0.05 800,000 0.16 years May 11, 2018 May 11, 2023 0.06 500,000 0.69 years May 22, 2018 May 22, 2023 0.07 450,000 0.72 years December 14, 2020 December 14, 2025 0.05 2,100,000 3.29 years January 28, 2021 January 28, 2026 0.14 2,000,000 3.41 years February 4, 2021 February 4, 2026 0.18 100,000 3.43 years February 5, 2021 February 5, 2026 0.18 300,000 3.44 years April 27, 2021 April 27, 2026 0.12 100,000 3.66 years May 28, 2021 May 28, 2026 0.12 50,000 3.74 years September 01, 2021 September 01, 2026 0.08 500,000 4.01 years December 06, 2021 December 06, 2026 0.07 1,000,000 4.27 years August 18, 2022 August 18, 2027 0.06 2,000,000 4.97 years Balance outstanding and exercisable 0.08 9,900,000 3.30 years *As at August 31, 2022 the market price of the Company's common shares was $0.048 per share. The intrinsic value of the stock options was $0. Warrants There were no warrants issued during the year ended August 31, 2022. During the year ended August 31, 2021, the Company issued 1,500,000 warrants attached to units in private placements. A summary of warrants as at August 31, 2022 and August 31, 2021 is as follows: Weighted Average Number of warrants Exercise Price Balance, August 31, 2020 13,236,869 $ 0.05 Issued 1,500,000 0.09 Forfeited (2,300,000 ) 0.05 Exercised (2,720,000 ) 0.04 Balance, August 31, 2021 9,716,869 $ 0.05 Forfeited (1,952,500 ) 0.08 Exercised (2,791,000 ) 0.05 Balance, August 31, 2022 4,973,369 $ 0.04 The Company has the following warrants outstanding as at August 31, 2022: Issue Date Expiry Date Exercise Price Number of Warrants * March 27, 2019 March 27, 2023 0.04 4,973,369 0.04 4,973,369 *Each warrant entitles a holder to purchase one common share. |
COMMITMENTS
COMMITMENTS | 12 Months Ended |
Aug. 31, 2022 | |
Commitments and Contingencies Disclosure [Abstract] | |
COMMITMENTS [Text Block] | 11. COMMITMENTS The Company has a consulting agreement with the President of the Company for corporate administration and consulting services for $9,500 per month plus goods and services tax ("GST") on a continuing basis. The Company has a consulting agreement with the CFO of the Company for corporate administration and consulting services for $5,000 per quarter plus goods and services tax ("GST") on a continuing basis. The Company has a rental agreement for a corporate office for CAD$1,100 per month plus GST. The agreement expires December 31, 2022. |
INCOME TAXES
INCOME TAXES | 12 Months Ended |
Aug. 31, 2022 | |
Income Tax Disclosure [Abstract] | |
INCOME TAXES [Text Block] | 12. INCOME TAXES The following table reconciles the income tax benefit at the U.S. Federal statutory income tax rates to income tax benefit at the Company's effective tax rates at August 31, 2022 and 2021: August 31, August 31, Income (loss) before taxes $ 1,974,407 $ (389,368 ) Statutory tax rate 21.0% 21.0% Expected income tax expense (recovery) 414,625 (81,767 ) Non-deductible items 34,257 62,515 Change in enacted rates and other (26,649 ) 3,952 Change in valuation allowance (422,234 ) 15,300 Income tax expense (recovery) $ - $ - Deferred taxes reflect the tax effects of temporary differences between the carrying amount of assets and liabilities for financial reporting purposes. Deferred tax assets (liabilities) at August 31, 2022 and 2021 are comprised of the following: August 31, August 31, Net operating loss carry forwards $ 2,154,456 $ 2,795,131 Marketable securities 207,613 2,549 Mineral property 64,364 50,987 Capital loss carry forwards 4,526 4,526 2,430,960 2,853,193 Valuation allowance 2,430,960 2,853,193 Deferred tax assets (liabilities) $ - $ - The Company has net operating loss carry forwards of approximately $10,259,316 (2021 - $14,266,681) a portion of which may be carried forward up to 20 years to apply against future taxable income for US tax purposes, subject to the final determination by the taxation authority, expiring in the following years. Future tax assets have not been recognized because it is not probable that future taxable profit will be available against which the Company can utilize the benefits therefrom. The expiry of the Company’s non-capital tax loss carryforwards are as follows: Expiry Year Amount 2030 $ 1,057,783 2031 - 2032 611,284 2033 379,241 2034 4,641,005 2035 1,207,633 2036 525,587 2037 801,509 2038 650,398 2039 343 2040 - 2041 384,533 Balance – August 31, 2022 $ 10,259,316 |
SEGMENTED INFORMATION
SEGMENTED INFORMATION | 12 Months Ended |
Aug. 31, 2022 | |
Segment Reporting [Abstract] | |
SEGMENTED INFORMATION [Text Block] | 13. SEGMENTED INFORMATION The Company’s operations involve the development of natural resources and green technologies. The Company is centrally managed and its chief operating decision maker, being the CEO, uses the consolidated and other financial information to make operational decisions and to assess the performance of the Company. The Company has increased its reportable segments from one to three during the year ended August 31, 2022. Long term Assets Amount United States of America $ 10,500 Balance – August 31, 2022 $ 10,500 August 31, 2022 Natural Technology Corporate Total Operating expenses $ (212,348 ) $ (808,800 ) $ (545,087 ) $ 1,566,235 Other income (expenses) (Note 4, 5, 6) 4,532,382 - (991,740 ) 3,540,642 Segment income (loss) $ 4,320,034 $ (808,800 ) $ (1,536,827 ) $ 1,974,407 Total Assets (Note 4, 5) $ 10,500 $ - $ 3,203,141 $ 3,213,641 |
SUBSEQUENT EVENTS
SUBSEQUENT EVENTS | 12 Months Ended |
Aug. 31, 2022 | |
Subsequent Events [Abstract] | |
SUBSEQUENT EVENTS [Text Block] | 14. SUBSEQUENT EVENTS Management has evaluated subsequent events through the date these financial statements were issued. Based on our evaluation the are no material events have occurred that require disclosure. |
SIGNIFICANT ACCOUNTING POLICI_2
SIGNIFICANT ACCOUNTING POLICIES (Policies) | 12 Months Ended |
Aug. 31, 2022 | |
Accounting Policies [Abstract] | |
Basis of Presentation [Policy Text Block] | a. Basis of Presentation The accompanying financial statements have been prepared in accordance with U.S. generally accepted accounting principles. |
Mineral Properties [Policy Text Block] | b. Mineral Properties Acquisition costs of mineral rights are initially capitalized as incurred while exploration and pre-extraction expenditures are expensed as incurred until such time proven or probable reserves are established for that project. Acquisition costs include cash consideration and the fair market value of shares issued on the acquisition of mineral properties. Expenditures relating to exploration activities are expensed as incurred and expenditures relating to pre-extraction activities are expensed as incurred until such time proven or probable reserves are established for that project, after which subsequent expenditures relating to development activities for that particular project are capitalized as incurred. Where proven and probable reserves have been established, the project's capitalized expenditures are depleted over proven and probable reserves using the units-of production method upon commencement of production. Where proven and probable reserves have not been established, the project's capitalized expenditures are depleted over the estimated extraction life using the straight-line method upon commencement of extraction. The Company has not established proven or probable reserves for any of its projects. The carrying values of the mineral rights are assessed for impairment by management on a quarterly basis and as required whenever indicators of impairment exist. An impairment loss is recognized if it is determined that the carrying value is not recoverable and exceeds fair value. |
Stock-Based Compensation [Policy Text Block] | c. Stock-Based Compensation The Company followed Accounting Standards Codification ("ASC") 718, "Compensation - Stock Compensation", to account for its stock options and similar equity instruments issued. Accordingly, compensation costs attributable to stock options or similar equity instruments granted are measured at the fair value at the grant date, and expensed over the expected vesting period. ASC 718 requires excess tax benefits be reported as a financing cash inflow rather than as a reduction of taxes paid. |
Accounting Estimates [Policy Text Block] | d. Accounting Estimates The preparation of financial statements in conformity with U.S GAAP requires us to make certain estimates, judgements and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Some of the Company's accounting policies require us to make subjective judgments, often as a result of the need to make estimates of matters that are inherently uncertain. These accounting policies involve critical accounting estimates because they are particularly dependent on estimates and assumptions made by management about matters that are highly uncertain at the time the accounting estimates are made. Although we have used our best estimates based on facts and circumstances available to us at the time, different estimates reasonably could have been used. Changes in the accounting estimates used by the Company are reasonably likely to occur from time to time, which may have a material effect on the presentation of financial condition and results of operations. The Company reviews these estimates, judgments and assumptions periodically and reflect the effects of revisions in the period in which they are deemed to be necessary. We believe that these estimates are reasonable; however, actual results could differ from these estimates. Significant accounting estimates and assumptions are used for, but not limited to: a) Judgement is required in determining whether deferred tax assets are recognized on the balance sheet. The recognition of deferred tax assets requires management to assess the likelihood that the Company will generate taxable income in future periods to utilize the deferred tax assets. Due to the Company's history of losses, deferred tax assets have not been recognized by the Company. b) The Company provides compensation benefits to its employees, directors, officers, and consultants, through a stock option plan. The fair value of each option award is estimated on the date of grant using the Black-Scholes option pricing model. Expected volatility assumption used in the model is based on the historical volatility of the Company's share price. The Company uses historical data to estimate the period of option exercises for use in the valuation model. The risk-free interest rate for the expected term of the option is based on the yields of government bonds. Changes in these assumptions, especially the share price volatility and the expected life determination could have a material impact on the Company's profit and loss for the periods presented. All estimates used in the model are based on historical data which may not be representative of future results. c) The Company at times grants common shares in lieu of cash to certain vendors for their services to the Company. The Company recognizes the associated cost in the same period and manner as if the Company paid cash for the services provided by calculating the fair value of the share offering at the cost of the service provided. |
Earnings Per Share [Policy Text Block] | e. Earnings Per Share Loss per share is computed using the weighted average number of shares outstanding during the period. |
Foreign Currency Translations [Policy Text Block] | f. Foreign Currency Translations The Company's operations are located in the United States of America and has its office in Canada. The Company maintains its accounting records in U.S. Dollars, as follows: At the transaction date, each asset, liability, revenue and expense that was acquired or incurred in a foreign currency is translated into U.S. dollars by the using of the exchange rate in effect at that date. At the year end, monetary assets and liabilities are translated at the exchange rate in effect at that date. The resulting foreign exchange gains and losses are included in operations. |
Financial Instruments [Policy Text Block] | g. Financial Instruments ASC 820 "Fair Value Measurements and Disclosures" requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. ASC 820 establishes a fair value hierarchy based on the level of independent, objective evidence surrounding the inputs used to measure fair value. A financial instrument's categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. ASC 820 prioritizes the inputs into three levels that may be used to measure fair value: Level 1 - Quoted prices in active markets for identical assets or liabilities; Level 2 - Inputs other than quoted prices included within Level 1 that are either directly or indirectly observable; and Level 3 - Unobservable inputs that are supported by little or no market activity, therefore requiring an entity to develop its own assumptions about the assumptions that market participants would use in pricing. The Company's financial instruments consist primarily of cash, marketable securities, The Company's operations are in United States of America and Canada, which results in exposure to market risks from changes in foreign currency rates. The financial risk is the risk to the Company's operations that arise from fluctuations in foreign exchange rates and the degree of volatility of these rates. Currently, the Company does not use derivative instruments to reduce its exposure to foreign currency risk. |
Income Taxes [Policy Text Block] | h. Income Taxes The Company has adopted ASC 740, "Income Taxes", which requires the Company to recognize deferred tax liabilities and assets for the expected future tax consequences of events that have been recognized in the Company's financial statements or tax returns using the liability method. Under this method, deferred tax liabilities and assets are determined based on the temporary differences between the financial statement and tax bases of assets and liabilities using enacted tax rates in effect in the year in which the differences are expected to reverse. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the period that includes the enactment date. In addition, a valuation allowance is established to reduce any deferred tax asset for which it is determined that it is more likely than not that some portion of the deferred tax asset will not be realized. |
Long-Lived Assets Impairment [Policy Text Block] | i. Long-Lived Assets Impairment In accordance with ASC 360, "Accounting for Impairment or Disposal of Long Lived Assets", the carrying value of long lived assets are tested for recoverability whenever events or changes in circumstances indicate that its carrying amount may not be recoverable. The Company recognizes impairment when the sum of the expected undiscounted future cash flows is less than the carrying amount of the asset. Impairment losses, if any, are measured as the excess of the carrying amount of the asset over its estimated fair value. |
Asset Retirement Obligations [Policy Text Block] | j. Asset Retirement Obligations The Company accounts for asset retirement obligations in accordance with the provisions of ASC 410, "Asset Retirement and Environmental Obligations". ASC 410 requires the Company to record the fair value of an asset retirement obligation as a liability in the period in which it incurs a legal obligation associated with the retirement of tangible long-lived assets that result from the acquisition, construction, development and/or normal use of the assets. The Company does not believe it has any asset retirement obligation as of August 31, 2022 and 2021. |
Comprehensive Income [Policy Text Block] | k. Comprehensive Income The Company has adopted ASC 220, "Comprehensive Income", which establishes standards for reporting and display of comprehensive income, its components and accumulated balances. The Company is disclosing this information on its Statement of Stockholders' Deficiency. Comprehensive income comprises equity except those transactions resulting from investments by owners and distributions to owners. |
Concentration of credit risk [Policy Text Block] | l. Concentration of credit risk The Company places its cash with high credit quality financial institutions. |
Commitments and Contingencies [Policy Text Block] | m. Commitments and Contingencies In accordance with ASC 450-20, "Accounting for Contingencies", the Company records accruals for such loss contingencies when it is probable that a liability has been incurred and the amount of loss can be reasonably estimated. In the event that estimates or assumptions prove to differ from actual results, adjustments are made in subsequent periods to reflect more current information. Historically, the Company has not experienced any material claims. |
Research and Development [Policy Text Block] | n. Research and Development Research and development costs are expensed as incurred. |
MARKETABLE SECURITIES (Tables)
MARKETABLE SECURITIES (Tables) | 12 Months Ended |
Aug. 31, 2022 | |
Investments, Debt and Equity Securities [Abstract] | |
Schedule of movement in marketable securities [Table Text Block] | Balance, August 31, 2020 $ 24,354 Additions 17,705 Proceeds from disposals (21,385 ) Unrealized loss (5,680 ) Balance, August 31, 2021 $ 14,994 Additions 1 3,432,382 Unrealized loss (923,533 ) Unrealized foreign exchange loss ( 62,388 ) Proceeds from disposal ( 10,064 ) Loss on disposal (7,641 ) Balance, August 31, 2022 $ 2,443,750 1 |
TECHNOLOGY DEVELOPMENT (Tables)
TECHNOLOGY DEVELOPMENT (Tables) | 12 Months Ended |
Aug. 31, 2022 | |
Technology Development [Abstract] | |
Schedule of consideration for purchase of Hydrogen Technology [Table Text Block] | Consideration for Purchase of Hydrogen Technology Amount $ 2,000,000 shares at FV 0.0502 (Adjusted closing price on the date of the issuance) 100,400 Cash Payment 25,000 Total 125,400 |
STOCK OPTIONS AND WARRANTS (Tab
STOCK OPTIONS AND WARRANTS (Tables) | 12 Months Ended |
Aug. 31, 2022 | |
Share-based Payment Arrangement [Abstract] | |
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] | 2022 2021 Expected dividend yield 0.00% 0.00% Expected stock volatility 202% 98% Risk-free interest rate 2.26% 0.41% Expected life of options (years) 5.00 5.00 Expected forfeiture rate 0.00% 0.00% Grant date fair value per option $ 0.05 $ 0.06 |
Schedule Share-based Payment Arrangement, Option, Activity [Table Text Block] | Options Outstanding Weighted Average Number of Shares Exercise Price Balance, August 31, 2020 9,320,000 $ 0.06 Issued 5,150,000 0.10 Expired (1,100,000 ) 0.05 Exercised (3,293,224 ) 0.04 Balance, August 31, 2021 10,076,776 $ 0.08 Issued 3,500,000 0.07 Expired (3,450,000 ) 0.07 Exercised (226,776 ) 0.04 Balance, August 31, 2022 9,900,000 $ 0.08 |
Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table Text Block] | The Company has the following options outstanding and exercisable as at August 31, 2022: Issue Date Expiry Date Exercise Price Number of Options Remaining Life October 27, 2017 October 27, 2022 0.05 800,000 0.16 years May 11, 2018 May 11, 2023 0.06 500,000 0.69 years May 22, 2018 May 22, 2023 0.07 450,000 0.72 years December 14, 2020 December 14, 2025 0.05 2,100,000 3.29 years January 28, 2021 January 28, 2026 0.14 2,000,000 3.41 years February 4, 2021 February 4, 2026 0.18 100,000 3.43 years February 5, 2021 February 5, 2026 0.18 300,000 3.44 years April 27, 2021 April 27, 2026 0.12 100,000 3.66 years May 28, 2021 May 28, 2026 0.12 50,000 3.74 years September 01, 2021 September 01, 2026 0.08 500,000 4.01 years December 06, 2021 December 06, 2026 0.07 1,000,000 4.27 years August 18, 2022 August 18, 2027 0.06 2,000,000 4.97 years Balance outstanding and exercisable 0.08 9,900,000 3.30 years *As at August 31, 2022 the market price of the Company's common shares was $0.048 per share. The intrinsic value of the stock options was $0. |
Schedule of Stockholders' Equity Note, Warrants or Rights, Activity [Table Text Block] | Weighted Average Number of warrants Exercise Price Balance, August 31, 2020 13,236,869 $ 0.05 Issued 1,500,000 0.09 Forfeited (2,300,000 ) 0.05 Exercised (2,720,000 ) 0.04 Balance, August 31, 2021 9,716,869 $ 0.05 Forfeited (1,952,500 ) 0.08 Exercised (2,791,000 ) 0.05 Balance, August 31, 2022 4,973,369 $ 0.04 |
Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block] | Issue Date Expiry Date Exercise Price Number of Warrants * March 27, 2019 March 27, 2023 0.04 4,973,369 0.04 4,973,369 *Each warrant entitles a holder to purchase one common share. |
INCOME TAXES (Tables)
INCOME TAXES (Tables) | 12 Months Ended |
Aug. 31, 2022 | |
Income Tax Disclosure [Abstract] | |
Schedule of Effective Income Tax Rate Reconciliation [Table Text Block] | August 31, August 31, Income (loss) before taxes $ 1,974,407 $ (389,368 ) Statutory tax rate 21.0% 21.0% Expected income tax expense (recovery) 414,625 (81,767 ) Non-deductible items 34,257 62,515 Change in enacted rates and other (26,649 ) 3,952 Change in valuation allowance (422,234 ) 15,300 Income tax expense (recovery) $ - $ - |
Schedule of Deferred Tax Assets and Liabilities [Table Text Block] | August 31, August 31, Net operating loss carry forwards $ 2,154,456 $ 2,795,131 Marketable securities 207,613 2,549 Mineral property 64,364 50,987 Capital loss carry forwards 4,526 4,526 2,430,960 2,853,193 Valuation allowance 2,430,960 2,853,193 Deferred tax assets (liabilities) $ - $ - |
Schedule of non-capital tax loss carryforwards [Table Text Block] | Expiry Year Amount 2030 $ 1,057,783 2031 - 2032 611,284 2033 379,241 2034 4,641,005 2035 1,207,633 2036 525,587 2037 801,509 2038 650,398 2039 343 2040 - 2041 384,533 Balance – August 31, 2022 $ 10,259,316 |
SEGMENTED INFORMATION (Tables)
SEGMENTED INFORMATION (Tables) | 12 Months Ended |
Aug. 31, 2022 | |
Segment Reporting [Abstract] | |
Schedule of Long term Assets [Table Text Block] | Long term Assets Amount United States of America $ 10,500 Balance – August 31, 2022 $ 10,500 |
Schedule of Segmented Information [Table Text Block] | August 31, 2022 Natural Technology Corporate Total Operating expenses $ (212,348 ) $ (808,800 ) $ (545,087 ) $ 1,566,235 Other income (expenses) (Note 4, 5, 6) 4,532,382 - (991,740 ) 3,540,642 Segment income (loss) $ 4,320,034 $ (808,800 ) $ (1,536,827 ) $ 1,974,407 Total Assets (Note 4, 5) $ 10,500 $ - $ 3,203,141 $ 3,213,641 |
GOING CONCERN UNCERTAINTY (Narr
GOING CONCERN UNCERTAINTY (Narrative) (Details) - USD ($) | 12 Months Ended | |
Aug. 31, 2022 | Aug. 31, 2021 | |
Going Concern Uncertainty [Abstract] | ||
Working capital (deficit) | $ 2,845,286 | $ (5,841) |
Cumulative losses | $ (12,694,988) | $ (14,669,395) |
MARKETABLE SECURITIES (Narrativ
MARKETABLE SECURITIES (Narrative) (Details) | 12 Months Ended | ||||
May 04, 2022 $ / shares | May 04, 2022 USD ($) shares | Aug. 31, 2022 $ / shares shares | Aug. 31, 2022 USD ($) shares | Aug. 31, 2021 USD ($) | |
Marketable Securities [Line Items] | |||||
Proceeds from mineral property sale | $ | $ 1,100,000 | $ 0 | |||
Cypress Development Corp [Member] | |||||
Marketable Securities [Line Items] | |||||
Number of shares received for mineral property sale | 3,000,000 | ||||
Proceeds from mineral property sale | $ | $ 1,100,000 | ||||
Number of shares invested | 3,000,000 | 3,000,000 | |||
Investment value, closing rate per share | $ / shares | $ 1.63 | $ 1.2 | |||
Investment value, discount percentage. | 10% | 11% | |||
Traded after four months and one day of closing date [Member] | Cypress Development Corp [Member] | |||||
Marketable Securities [Line Items] | |||||
Number of shares tradeable during period | 1,000,000 | ||||
Traded three months following closing date [Member] | Cypress Development Corp [Member] | |||||
Marketable Securities [Line Items] | |||||
Number of shares tradeable during period | 1,000,000 |
MARKETABLE SECURITIES - Schedul
MARKETABLE SECURITIES - Schedule of movement in marketable securities (Details) - USD ($) | 12 Months Ended | |
Aug. 31, 2022 | Aug. 31, 2021 | |
Marketable Securities [Line Items] | ||
Additions | $ 0 | $ 17,705 |
Unrealized loss | (923,533) | (5,680) |
Unrealized foreign exchange loss on marketable securities | 62,388 | 0 |
Proceeds from disposal | (10,064) | (74,873) |
Loss on disposal | (7,641) | 53,488 |
Cypress Development Corp [Member] | ||
Marketable Securities [Line Items] | ||
Beginning Balance | 14,994 | 24,354 |
Additions | 3,432,382 | 17,705 |
Unrealized loss | (923,533) | (5,680) |
Unrealized foreign exchange loss on marketable securities | (62,388) | |
Proceeds from disposal | (10,064) | (21,385) |
Loss on disposal | (7,641) | |
Ending Balance | $ 2,443,750 | $ 14,994 |
MINERAL PROPERTY (Narrative) (D
MINERAL PROPERTY (Narrative) (Details) - USD ($) | 1 Months Ended | 12 Months Ended | |||
May 04, 2022 | Feb. 11, 2020 | Feb. 25, 2022 | Oct. 30, 2020 | Aug. 31, 2022 | |
Mineral Industries [Line Items] | |||||
Percentage of interest in land rights | 100% | ||||
Clayton Valley [Member] | |||||
Mineral Industries [Line Items] | |||||
Percentage of royalty agreement | 1% | 1% | |||
Total selling price | $ 200,000 | $ 250,000 | |||
Cypress Development Corp [Member] | |||||
Mineral Industries [Line Items] | |||||
Number of shares received for mineral property sale | 3,000,000 | ||||
Remainder of cash received | $ 1,100,000 | ||||
West Tonopah Property [Member] | |||||
Mineral Industries [Line Items] | |||||
Cash consideration for unpatented mineral claims | $ 10,500 |
TECHNOLOGY DEVELOPMENT (Narrati
TECHNOLOGY DEVELOPMENT (Narrative) (Details) | 12 Months Ended | ||||
Dec. 06, 2021 USD ($) shares | Dec. 14, 2020 USD ($) shares | Aug. 31, 2022 USD ($) | Aug. 31, 2021 USD ($) | Dec. 14, 2020 $ / shares | |
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] | |||||
Research and development costs | $ 808,800 | $ 12,566 | |||
United States Patent And Trademark Office [Member] | |||||
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] | |||||
Number of shares issued | shares | 1,000,000 | ||||
Additional common shares in escrow | shares | 1,000,000 | ||||
Shares issued, price per share | $ / shares | $ 0.0345 | ||||
Purchase price | $ 69,000 | ||||
Patent #6,024,086 - Solar energy [Member] | United States Patent And Trademark Office [Member] | |||||
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] | |||||
Ownership percentage | 100% | ||||
Hydrogen Technology [Member] | |||||
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] | |||||
Cash payment | $ 25,000 | 25,000 | |||
Ownership percentage | 100% | ||||
Number of shares issued | shares | 1,000,000 | ||||
Additional common shares in escrow | shares | 1,000,000 | ||||
Research and development costs | 168,016 | ||||
Acquisition costs | $ 125,400 |
TECHNOLOGY DEVELOPMENT - Schedu
TECHNOLOGY DEVELOPMENT - Schedule of consideration for purchase of Hydrogen Technology (Details) - USD ($) | 12 Months Ended | |
Dec. 06, 2021 | Aug. 31, 2022 | |
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] | ||
Shares issued for hydrogen technology | $ 100,400 | |
Hydrogen Technology [Member] | ||
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] | ||
Shares issued for hydrogen technology | 100,400 | |
Cash payment | $ 25,000 | 25,000 |
Total | $ 125,400 | |
Shares issued for hydrogen technology (shares) | 2,000,000 | |
Stock price per share | $ 0.0502 |
BATTERY MANAGEMENT TECHNOLOGY_2
BATTERY MANAGEMENT TECHNOLOGY ("BMT") (Narrative) (Details) - USD ($) | 1 Months Ended | 12 Months Ended | |
Dec. 17, 2021 | Aug. 31, 2022 | Aug. 31, 2021 | |
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] | |||
Research and development expense | $ 808,800 | $ 12,566 | |
Battery Management Technology [Member] | |||
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] | |||
Research and development expense | $ 480,000 | ||
Definitive Purchase and Sale Agreement [Member] | Mr. Mark Snyder and Paul Sandler [Member] | Battery Management Technology [Member] | |||
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] | |||
Equity ownership percentage | 100% | ||
Cash | $ 30,000 | ||
Number of shares issued | 10,000,000 | ||
Number of common shares in escrow | 5,000,000 | ||
Purchase value of BMT | $ 450,000 | ||
Definitive Purchase and Sale Agreement [Member] | Mr. Mark Snyder and Paul Sandler [Member] | Battery Management Technology [Member] | Joint Venture [Member] | |||
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] | |||
Percentage of controlling interest | 51% |
RELATED PARTY TRANSACTIONS (Nar
RELATED PARTY TRANSACTIONS (Narrative) (Details) - USD ($) | 1 Months Ended | 12 Months Ended | ||
Dec. 06, 2021 | Aug. 18, 2022 | Aug. 31, 2022 | Aug. 31, 2021 | |
Related Party Transaction [Line Items] | ||||
Accounts payable to related party | $ 64,409 | $ 111,659 | ||
Stock options granted (shares) | 2,000,000 | 3,500,000 | 5,150,000 | |
President [Member] | ||||
Related Party Transaction [Line Items] | ||||
Consulting fees | $ 38,000 | $ 0 | ||
Accounts payable to related party | 64,409 | 111,659 | ||
Stock options granted (shares) | 250,000 | |||
Value of options granted | $ 12,205 | |||
Chief Financial Officer [Member] | ||||
Related Party Transaction [Line Items] | ||||
Consulting fees | 769 | 0 | ||
Accounts payable to related party | $ 0 | $ 0 | ||
Stock options granted (shares) | 1,000,000 | |||
Value of options granted | $ 40,543 | |||
Director [Member] | ||||
Related Party Transaction [Line Items] | ||||
Stock options granted (shares) | 1,000,000 | |||
Value of options granted | $ 40,543 |
COMMON STOCK (Narrative) (Detai
COMMON STOCK (Narrative) (Details) - USD ($) $ / shares in Units, $ in Thousands | 1 Months Ended | 12 Months Ended | |||||
Dec. 06, 2021 | Jan. 14, 2021 | Dec. 14, 2020 | Feb. 25, 2022 | Dec. 17, 2021 | Aug. 31, 2022 | Aug. 31, 2021 | |
Stockholders Equity Note [Line Items] | |||||||
Number of units issued in final tranche of private placement | 3,000,000 | ||||||
Units issue price in final tranche of private placement | $ 0.06 | ||||||
Gross proceeds from issuance of units in final tranche of private placement | $ 180,000 | ||||||
Description of units issuance in private placement | Each unit consists of one common share of the Company and one half (0.5) of a non-transferable share purchase warrant, each warrant entitling the holder to purchase one additional common share of the Company for a period of 12 months from the date of issuance | ||||||
Purchase price per share to purchase one additional common share | $ 0.09 | ||||||
Number of common shares issued in exercise of options | 113,388 | 3,293,224 | |||||
Number of common shares issued in exercise of warrants | 2,791,000 | 2,720,000 | |||||
Common stock, shares issued | 155,116,088 | 139,211,700 | |||||
Common stock, shares outstanding | 155,116,088 | 139,211,700 | |||||
Number of shares held in escrow | 7,000,000 | 1,000,000 | |||||
Hydrogen Technology [Member] | |||||||
Stockholders Equity Note [Line Items] | |||||||
Number of shares issued | 1,000,000 | ||||||
Additional common shares in escrow | 1,000,000 | ||||||
Definitive agreement [Member] | |||||||
Stockholders Equity Note [Line Items] | |||||||
Number of shares issued | 1,000,000 | 5,000,000 | |||||
Additional common shares in escrow | 1,000,000 | 5,000,000 | |||||
Consultant 1 [Member] | |||||||
Stockholders Equity Note [Line Items] | |||||||
Number of shares issued | 1,000,000 | ||||||
Common Stock [Member] | |||||||
Stockholders Equity Note [Line Items] | |||||||
Number of common shares issued in exercise of options | 113,388 | 3,020,000 | |||||
Number of common shares issued in exercise of warrants | 2,791,000 | 2,720,000 |
STOCK OPTIONS AND WARRANTS (Nar
STOCK OPTIONS AND WARRANTS (Narrative) (Details) - USD ($) | 1 Months Ended | 12 Months Ended | ||||||||||
Dec. 06, 2021 | Sep. 09, 2021 | Feb. 05, 2021 | Feb. 04, 2021 | Dec. 14, 2020 | Nov. 12, 2020 | Aug. 18, 2022 | May 28, 2021 | Apr. 27, 2021 | Jan. 28, 2021 | Aug. 31, 2022 | Aug. 31, 2021 | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||||||
Expected life of options (years) | 5 years | 5 years | ||||||||||
Stock options exercised | $ 0 | $ 95,992 | ||||||||||
Stock options granted (shares) | 2,000,000 | 3,500,000 | 5,150,000 | |||||||||
Stock options granted exercise price | $ 0.06 | $ 0.07 | $ 0.1 | |||||||||
Stock option expiration date | Aug. 18, 2027 | |||||||||||
Stock based compensation | $ 163,130 | $ 297,691 | ||||||||||
Stock options exercised (shares) | 113,388 | 3,293,224 | ||||||||||
Number of options, exercised | (226,776) | (3,293,224) | ||||||||||
Stock options expired | 3,450,000 | 1,100,000 | ||||||||||
Intrinsic value of stock options | $ 0 | |||||||||||
Number of warrants issued | 1,500,000 | |||||||||||
Market price of common shares | $ 0.048 | |||||||||||
Number of warrants exercised | 2,791,000 | 2,720,000 | ||||||||||
Warrants exercised, exercise price | $ 0.05 | $ 0.04 | ||||||||||
Number of warrants forfeited | 1,952,500 | 2,300,000 | ||||||||||
Proceeds from stock option exercised | $ 0 | $ 95,992 | ||||||||||
Maximum [Member] | ||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||||||
Number of Common Shares reserved, allotted and issued pursuant to Options | 17,400,000 | |||||||||||
Expected life of options (years) | 5 years | |||||||||||
One Consultant [Member] | ||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||||||
Stock options granted (shares) | 500,000 | 500,000 | ||||||||||
Stock options granted exercise price | $ 0.07 | $ 0.05 | ||||||||||
Stock option expiration date | Dec. 06, 2026 | Nov. 12, 2025 | ||||||||||
Consultants and officers [Member] | ||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||||||
Stock options granted (shares) | 2,100,000 | |||||||||||
Stock options granted exercise price | $ 0.05 | |||||||||||
Stock option expiration date | Dec. 14, 2025 | |||||||||||
Consultant 2 [Member] | ||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||||||
Stock options granted (shares) | 250,000 | 2,000,000 | ||||||||||
Stock options granted exercise price | $ 0.07 | $ 0.14 | ||||||||||
Stock option expiration date | Dec. 06, 2026 | Jan. 28, 2026 | ||||||||||
Consultant 3 [Member] | ||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||||||
Stock options granted (shares) | 500,000 | 100,000 | ||||||||||
Stock options granted exercise price | $ 0.08 | $ 0.18 | ||||||||||
Stock option expiration date | Sep. 09, 2026 | Feb. 04, 2026 | ||||||||||
Three Consultants [Member] | ||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||||||
Stock options granted (shares) | 300,000 | |||||||||||
Stock options granted exercise price | $ 0.18 | |||||||||||
Stock option expiration date | Feb. 05, 2026 | |||||||||||
Consultant 4 [Member] | ||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||||||
Stock options granted (shares) | 100,000 | |||||||||||
Stock options granted exercise price | $ 0.12 | |||||||||||
Stock option expiration date | Apr. 27, 2026 | |||||||||||
Consultant 5 [Member] | ||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||||||
Stock options granted (shares) | 50,000 | |||||||||||
Stock options granted exercise price | $ 0.12 | |||||||||||
Stock option expiration date | May 28, 2026 | |||||||||||
Chief Financial Officer [Member] | ||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||||||
Stock options granted (shares) | 1,000,000 | |||||||||||
Director [Member] | ||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||||||
Stock options granted (shares) | 500,000 | |||||||||||
President [Member] | ||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||||||
Stock options granted (shares) | 250,000 | |||||||||||
Stock options granted exercise price | $ 0.07 | |||||||||||
Stock option expiration date | Dec. 06, 2026 | |||||||||||
Warrants attached to units [Member] | ||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||||||
Number of warrants issued | 1,500,000 |
STOCK OPTIONS AND WARRANTS - Sc
STOCK OPTIONS AND WARRANTS - Schedule of share-based payment award, stock options, valuation assumptions (Details) - $ / shares | 12 Months Ended | |
Aug. 31, 2022 | Aug. 31, 2021 | |
Share-based Payment Arrangement [Abstract] | ||
Expected dividend yield | 0% | 0% |
Expected stock volatility | 202% | 98% |
Risk-free interest rate | 2.26% | 0.41% |
Expected life of options (years) | 5 years | 5 years |
Expected forfeiture rate | 0% | 0% |
Grant date fair value per option | $ 0.05 | $ 0.06 |
STOCK OPTIONS AND WARRANTS - _2
STOCK OPTIONS AND WARRANTS - Schedule of share-based compensation, stock options, activity (Details) - $ / shares | 1 Months Ended | 12 Months Ended | |
Aug. 18, 2022 | Aug. 31, 2022 | Aug. 31, 2021 | |
Share-based Payment Arrangement [Abstract] | |||
Number of options, beginning of period | 10,076,776 | 9,320,000 | |
Options outstanding, weighted average exercise price, beginning of period | $ 0.08 | $ 0.06 | |
Number of options, issued | 2,000,000 | 3,500,000 | 5,150,000 |
Weighted average exercise price of options issued | $ 0.06 | $ 0.07 | $ 0.1 |
Number of options, expired | (3,450,000) | (1,100,000) | |
Weighted average exercise price of options expired | $ 0.07 | $ 0.05 | |
Number of options, exercised | (226,776) | (3,293,224) | |
Weighted average exercise price of options exercised | $ 0.04 | $ 0.04 | |
Number of options, end of period | 9,900,000 | 10,076,776 | |
Options outstanding, weighted average exercise price, end of period | $ 0.08 | $ 0.08 |
STOCK OPTIONS AND WARRANTS - Di
STOCK OPTIONS AND WARRANTS - Disclosure of share-based compensation arrangements by share-based payment award (Details) - $ / shares | 1 Months Ended | 12 Months Ended | ||
Aug. 18, 2022 | Aug. 31, 2022 | Aug. 31, 2021 | Aug. 31, 2020 | |
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items] | ||||
Expiry Date | Aug. 18, 2027 | |||
Exercise prices | $ 0.08 | $ 0.08 | $ 0.06 | |
Options outstanding and exercisable Number of shares | 9,900,000 | 10,076,776 | 9,320,000 | |
Options outstanding and exercisable Remaining contractual life | 3 years 3 months 18 days | |||
October 27, 2017 [Member] | ||||
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items] | ||||
Issue Date | Oct. 27, 2017 | |||
Expiry Date | Oct. 27, 2022 | |||
Exercise prices | $ 0.05 | |||
Options outstanding and exercisable Number of shares | 800,000 | |||
Options outstanding and exercisable Remaining contractual life | 1 month 28 days | |||
May 11, 2018 [Member] | ||||
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items] | ||||
Issue Date | May 11, 2018 | |||
Expiry Date | May 11, 2023 | |||
Exercise prices | $ 0.06 | |||
Options outstanding and exercisable Number of shares | 500,000 | |||
Options outstanding and exercisable Remaining contractual life | 8 months 8 days | |||
May 22, 2018 [Member] | ||||
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items] | ||||
Issue Date | May 22, 2018 | |||
Expiry Date | May 22, 2023 | |||
Exercise prices | $ 0.07 | |||
Options outstanding and exercisable Number of shares | 450,000 | |||
Options outstanding and exercisable Remaining contractual life | 8 months 19 days | |||
December 14, 2020 [Member] | ||||
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items] | ||||
Issue Date | Dec. 14, 2020 | |||
Expiry Date | Dec. 14, 2025 | |||
Exercise prices | $ 0.05 | |||
Options outstanding and exercisable Number of shares | 2,100,000 | |||
Options outstanding and exercisable Remaining contractual life | 3 years 3 months 14 days | |||
January 28, 2021 [Member] | ||||
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items] | ||||
Issue Date | Jan. 28, 2021 | |||
Expiry Date | Jan. 28, 2026 | |||
Exercise prices | $ 0.14 | |||
Options outstanding and exercisable Number of shares | 2,000,000 | |||
Options outstanding and exercisable Remaining contractual life | 3 years 4 months 28 days | |||
February 4, 2021 [Member] | ||||
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items] | ||||
Issue Date | Feb. 04, 2021 | |||
Expiry Date | Feb. 04, 2026 | |||
Exercise prices | $ 0.18 | |||
Options outstanding and exercisable Number of shares | 100,000 | |||
Options outstanding and exercisable Remaining contractual life | 3 years 5 months 4 days | |||
February 5, 2021 [Member] | ||||
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items] | ||||
Issue Date | Feb. 05, 2021 | |||
Expiry Date | Feb. 05, 2026 | |||
Exercise prices | $ 0.18 | |||
Options outstanding and exercisable Number of shares | 300,000 | |||
Options outstanding and exercisable Remaining contractual life | 3 years 5 months 8 days | |||
April 27, 2021 [Member] | ||||
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items] | ||||
Issue Date | Apr. 27, 2021 | |||
Expiry Date | Apr. 27, 2026 | |||
Exercise prices | $ 0.12 | |||
Options outstanding and exercisable Number of shares | 100,000 | |||
Options outstanding and exercisable Remaining contractual life | 3 years 7 months 28 days | |||
May 28, 2021 [Member] | ||||
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items] | ||||
Issue Date | May 28, 2021 | |||
Expiry Date | May 28, 2026 | |||
Exercise prices | $ 0.12 | |||
Options outstanding and exercisable Number of shares | 50,000 | |||
Options outstanding and exercisable Remaining contractual life | 3 years 8 months 26 days | |||
September 01, 2021 [Member] | ||||
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items] | ||||
Issue Date | Sep. 01, 2021 | |||
Expiry Date | Sep. 01, 2026 | |||
Exercise prices | $ 0.08 | |||
Options outstanding and exercisable Number of shares | 500,000 | |||
Options outstanding and exercisable Remaining contractual life | 4 years 3 days | |||
December 6, 2021 [Member] | ||||
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items] | ||||
Issue Date | Dec. 06, 2021 | |||
Expiry Date | Dec. 06, 2026 | |||
Exercise prices | $ 0.07 | |||
Options outstanding and exercisable Number of shares | 1,000,000 | |||
Options outstanding and exercisable Remaining contractual life | 4 years 3 months 7 days | |||
August 18, 2022 [Member] | ||||
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items] | ||||
Issue Date | Aug. 18, 2022 | |||
Expiry Date | Aug. 18, 2027 | |||
Exercise prices | $ 0.06 | |||
Options outstanding and exercisable Number of shares | 2,000,000 | |||
Options outstanding and exercisable Remaining contractual life | 4 years 11 months 19 days |
STOCK OPTIONS AND WARRANTS - _3
STOCK OPTIONS AND WARRANTS - Schedule of stockholders' equity note, warrants or rights, activity (Details) - $ / shares | 12 Months Ended | |
Aug. 31, 2022 | Aug. 31, 2021 | |
Share-based Payment Arrangement [Abstract] | ||
Number of warrants, Outstanding, Beginning of Period | 9,716,869 | 13,236,869 |
Weighted Average Exercise Price, Outstanding, Beginning of Period | $ 0.05 | $ 0.05 |
Number of warrants, Issued | 1,500,000 | |
Weighted Average Exercise Price, Issued | $ 0.09 | |
Number of warrants, Forfeited | (1,952,500) | (2,300,000) |
Weighted Average Exercise Price, Forfeited | $ 0.08 | $ 0.05 |
Number of warrants, Exercised | (2,791,000) | (2,720,000) |
Weighted Average Exercise Price, Exercised | $ 0.05 | $ 0.04 |
Number of warrants, Outstanding, End of Period | 4,973,369 | 9,716,869 |
Weighted Average Exercise Price, Outstanding, End of Period | $ 0.04 | $ 0.05 |
STOCK OPTIONS AND WARRANTS - _4
STOCK OPTIONS AND WARRANTS - Schedule of stockholders' equity note, warrants or rights (Details) - $ / shares | 12 Months Ended | ||
Aug. 31, 2022 | Aug. 31, 2021 | Aug. 31, 2020 | |
Class of Warrant or Right [Line Items] | |||
Exercise Price | $ 0.04 | ||
Number of Warrants | 4,973,369 | 9,716,869 | 13,236,869 |
March 27, 2019 [Member] | |||
Class of Warrant or Right [Line Items] | |||
Issue Date | Mar. 27, 2019 | ||
Expiry Date | Mar. 27, 2023 | ||
Exercise Price | $ 0.04 | ||
Number of Warrants | 4,973,369 |
COMMITMENTS (Narrative) (Detail
COMMITMENTS (Narrative) (Details) - USD ($) | 12 Months Ended | |
Aug. 31, 2022 | May 01, 2022 | |
Other Commitments [Line Items] | ||
Monthly office rent | $ 1,100 | |
President [Member] | ||
Other Commitments [Line Items] | ||
Corporate administration and consulting services per month/quarter plus goods and services tax | $ 9,500 | |
Chief Financial Officer [Member] | ||
Other Commitments [Line Items] | ||
Corporate administration and consulting services per month/quarter plus goods and services tax | $ 5,000 |
INCOME TAXES (Narrative) (Detai
INCOME TAXES (Narrative) (Details) - USD ($) | Aug. 31, 2022 | Aug. 31, 2021 |
Income Tax Disclosure [Abstract] | ||
Net operating loss carry forwards | $ 10,259,316 | $ 14,266,681 |
INCOME TAXES - Schedule of effe
INCOME TAXES - Schedule of effective income tax rate reconciliation (Details) - USD ($) | 12 Months Ended | |
Aug. 31, 2022 | Aug. 31, 2021 | |
Income Tax Disclosure [Abstract] | ||
Income (loss) before taxes | $ 1,974,407 | $ (389,368) |
Statutory tax rate | 21% | 21% |
Expected income tax expense (recovery) | $ 414,625 | $ (81,767) |
Non-deductible items | 34,257 | 62,515 |
Change in enacted rates and other | (26,649) | 3,952 |
Change in valuation allowance | (422,234) | 15,300 |
Income tax expense (recovery) | $ 0 | $ 0 |
INCOME TAXES - Schedule of defe
INCOME TAXES - Schedule of deferred tax assets and liabilities (Details) - USD ($) | Aug. 31, 2022 | Aug. 31, 2021 |
Deferred Tax Assets Liability [Line Items] | ||
Net operating loss carry forwards | $ 2,154,456 | $ 2,795,131 |
Capital loss carry forwards | 4,526 | 4,526 |
Deferred tax assets, gross | 2,430,960 | 2,853,193 |
Valuation allowance | 2,430,960 | 2,853,193 |
Deferred tax assets (liabilities) | 0 | 0 |
Marketable securities [Member] | ||
Deferred Tax Assets Liability [Line Items] | ||
Deferred tax assets, other | 207,613 | 2,549 |
Mineral property [Member] | ||
Deferred Tax Assets Liability [Line Items] | ||
Deferred tax assets, other | $ 64,364 | $ 50,987 |
INCOME TAXES - Schedule of non-
INCOME TAXES - Schedule of non-capital tax loss carryforwards (Details) - USD ($) | Aug. 31, 2022 | Aug. 31, 2021 |
Operating Loss Carryforwards [Line Items] | ||
Non-capital tax loss carryforwards | $ 10,259,316 | $ 14,266,681 |
2030 [Member] | ||
Operating Loss Carryforwards [Line Items] | ||
Non-capital tax loss carryforwards | 1,057,783 | |
2031 [Member] | ||
Operating Loss Carryforwards [Line Items] | ||
Non-capital tax loss carryforwards | 0 | |
2032 [Member] | ||
Operating Loss Carryforwards [Line Items] | ||
Non-capital tax loss carryforwards | 611,284 | |
2033 [Member] | ||
Operating Loss Carryforwards [Line Items] | ||
Non-capital tax loss carryforwards | 379,241 | |
2034 [Member] | ||
Operating Loss Carryforwards [Line Items] | ||
Non-capital tax loss carryforwards | 4,641,005 | |
2035 [Member] | ||
Operating Loss Carryforwards [Line Items] | ||
Non-capital tax loss carryforwards | 1,207,633 | |
2036 [Member] | ||
Operating Loss Carryforwards [Line Items] | ||
Non-capital tax loss carryforwards | 525,587 | |
2037 [Member] | ||
Operating Loss Carryforwards [Line Items] | ||
Non-capital tax loss carryforwards | 801,509 | |
2038 [Member] | ||
Operating Loss Carryforwards [Line Items] | ||
Non-capital tax loss carryforwards | 650,398 | |
2039 [Member] | ||
Operating Loss Carryforwards [Line Items] | ||
Non-capital tax loss carryforwards | 343 | |
2040 [Member] | ||
Operating Loss Carryforwards [Line Items] | ||
Non-capital tax loss carryforwards | 0 | |
2041 [Member] | ||
Operating Loss Carryforwards [Line Items] | ||
Non-capital tax loss carryforwards | $ 384,533 |
SEGMENTED INFORMATION (Narrativ
SEGMENTED INFORMATION (Narrative) (Details) | 12 Months Ended |
Aug. 31, 2022 Segment | |
Segment Reporting [Abstract] | |
Number of Reportable Segments | 3 |
SEGMENTED INFORMATION - Schedul
SEGMENTED INFORMATION - Schedule of long term assets (Details) $ in Thousands | Aug. 31, 2022 USD ($) |
Revenues from External Customers and Long-Lived Assets [Line Items] | |
Long term Assets | $ 10,500 |
United States of America [Member] | |
Revenues from External Customers and Long-Lived Assets [Line Items] | |
Long term Assets | $ 10,500 |
SEGMENTED INFORMATION - Sched_2
SEGMENTED INFORMATION - Schedule of reportable segments (Details) - USD ($) | 12 Months Ended | |
Aug. 31, 2022 | Aug. 31, 2021 | |
Segment Reporting Information [Line Items] | ||
Operating expenses | $ 1,566,235 | $ 614,782 |
Segment income (loss) | 1,974,407 | (389,368) |
Total Assets | 3,213,641 | $ 415,095 |
Operating Segments [Member] | ||
Segment Reporting Information [Line Items] | ||
Operating expenses | 1,566,235 | |
Other income (expenses) | 3,540,642 | |
Segment income (loss) | 1,974,407 | |
Total Assets | 3,213,641 | |
Operating Segments [Member] | Natural Resources [Member] | ||
Segment Reporting Information [Line Items] | ||
Operating expenses | (212,348) | |
Other income (expenses) | 4,532,382 | |
Segment income (loss) | 4,320,034 | |
Total Assets | 10,500 | |
Operating Segments [Member] | Technology [Member] | ||
Segment Reporting Information [Line Items] | ||
Operating expenses | (808,800) | |
Other income (expenses) | 0 | |
Segment income (loss) | (808,800) | |
Total Assets | 0 | |
Operating Segments [Member] | Corporate [Member] | ||
Segment Reporting Information [Line Items] | ||
Operating expenses | (545,087) | |
Other income (expenses) | (991,740) | |
Segment income (loss) | (1,536,827) | |
Total Assets | $ 3,203,141 |